Effect of circulating miR‑126 levels on intracranial aneurysms and their predictive value for the rupture of aneurysms: A systematic review and meta‑analysis.
aneurysm
aneurysmal rupture
biomarker
hemorrhage
microRNA-126
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
17
03
2023
accepted:
30
06
2023
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Intracranial aneurysm (IA) is a common cerebrovascular disease with a high risk of rupture. At present, the mechanisms underlying the formation and rupture of IAs is not clinically clear. MicroRNAs (miRNAs/miRs) are involved in the development of IAs. The present study aimed to determine the efficacy of circulating miRNA-126 (miR-126) levels as potential biomarkers for predicting aneurysmal ruptures. The present study searched comparative articles involving circulating miR-126 levels and intracranial aneurysms through electronic databases from 1980 to February, 2023. Collected variables included the first author's name, covered study period, publication year, total number of patients and age, and number of males. We collected information about the expression levels of circulating miR-126 in serum. Three articles met the eligibility criteria. The total number of patients was 379 [226 with IA rupture and 153 with non-rupture or/+ controls (healthy)]. The circulating miR-126 can be used as a biomarker for predicting aneurysmal rupture. Interestingly, an aneurysmal size >10 mm was associated with an IA rupture.
Identifiants
pubmed: 37522062
doi: 10.3892/etm.2023.12110
pii: ETM-26-2-12110
pmc: PMC10375441
doi:
Types de publication
Journal Article
Langues
eng
Pagination
411Informations de copyright
Copyright: © Mathioudakis et al.
Déclaration de conflit d'intérêts
DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have no competing interests.
Références
Acta Neurochir Suppl. 2015;120:13-5
pubmed: 25366592
PLoS One. 2017 May 1;12(5):e0176558
pubmed: 28459827
J Vasc Res. 2013;50(4):346-54
pubmed: 23860376
Mol Diagn Ther. 2020 Jun;24(3):351-364
pubmed: 32323261
Mol Clin Oncol. 2023 Jan 25;18(3):15
pubmed: 36798467
Future Sci OA. 2019 Nov 05;6(1):FSO431
pubmed: 31915532
Neurosurgery. 2003 Jul;53(1):123-33; discussion 133-5
pubmed: 12823881
BMC Neurol. 2014 Oct 10;14:188
pubmed: 25300531
Stroke Res Treat. 2013;2013:560305
pubmed: 23509668
J Cereb Blood Flow Metab. 2008 Jun;28(6):1204-11
pubmed: 18319732
World Neurosurg. 2020 Jan;133:e828-e834
pubmed: 31622680
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2378-82
pubmed: 22011750
J Neurosurg. 2002 Jan;96(1):64-70
pubmed: 11794606
Stroke. 2008 Apr;39(4):1103-8
pubmed: 18309169
Cerebrovasc Dis. 2017;43(3-4):139-144
pubmed: 28088803
Med Int (Lond). 2022 Nov 02;2(6):34
pubmed: 36699155
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Am J Transl Res. 2022 Jun 15;14(6):4372-4379
pubmed: 35836862
Future Sci OA. 2018 Jun 26;4(6):FSO313
pubmed: 30057790
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3245-3253
pubmed: 32271441
Clin Interv Aging. 2019 Jan 23;14:203-207
pubmed: 30774321
Curr Neurovasc Res. 2021;18(5):525-534
pubmed: 34923944
Surg Neurol. 2007 Jul;68(1):19-23
pubmed: 17586214